Why the study?
Is Holter monitoring as accurate as electrophysiologic testing for selecting effective antiarrhythmic drug therapy?
Is Holter monitoring as accurate as electrophysiologic testing for selecting effective antiarrhythmic drug therapy?
Answers are grounded in this paper and cite their sources.
Holter monitoring offers a simpler, safer, and cheaper initial alternative to electrophysiologic testing for antiarrhythmic drug selection, despite high long-term arrhythmia recurrence rates.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Jay W. Mason (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: